Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification

American Journal of Physiology - Cell Physiology

Volumn 271, Issue 5 40-5, 1996, Pages

  Myers, Damian E ^a   Huang, Wei Ning ^a   Larkins, Richard G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

glycated lipoproteins; oxidized low density lipoproteins; signal transduction

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROSTACYCLIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CATTLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0029830428     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.271.5.c1504     Document Type: Article

References (41)

1. Alexander, J. J., R. Miguel, and D. Graham. Competitive inhibition of LDL binding and uptake by HDL in aortic endothelial cells. J. Surg. Res. 49: 248-251, 1990.
2. Basu, S. K., J. L. Goldstein, R. G. W. Anderson, and M. J. Brown. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 73: 3178-3182, 1976.
3. Bedossa, P., T. Poynard, A. Abella, F. Paraf, G. Lemaigre, and E. Martin. Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries. Arch. Pathol. Lab. Med. 113: 777-780, 1989.
4. Block, L. H., M. M. Knorr, E. Vogt, R. Locher, W. Vetter, P. Groscurth, B.-Y. Qiao, D. Pometta, R. James, M. Regenass, and A. Pletscher. Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc. Natl. Acad. Sci. USA 85: 885-889, 1988.
5. Boyd, H. C., A. M. Gown, G. Wolfbauer, and A. Chait. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am. J. Pathol. 135: 815-825, 1989.
6. Brown, M. S., and J. L. Goldstein. The LDL receptor concept: clinical and therapeutic implications. Atherosclerosis Rev. 18: 85-93, 1988.
7. Camejo, G., S. O. Olofsson, F. Lopez, P. Carlsson, and G. Bondjers. Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis 8: 368-377, 1988.
8. Darbon, J.-M., J.-F. Tournier, J.-P. Tauber, and F. Bayard. Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J. Biol. Chem. 261: 8002-8008, 1986.
9. Fleisher, L. N., A. R. Tall, L. D. Witte, R. W. Miller, and P. J. Cannon. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J. Biol. Chem. 257: 6653-6655, 1982.
10. Ic. FEBS Lett. 71: 356-360, 1976.
11. Geling, N. G., I. S. Naumov, and A. S. Antonov. Prostacyclin formation by human aorta in different types of atherosclerotic lesion. Biomed. Biochim. Acta 43: S281-S283, 1984.
12. Graham, D. L., and J. F. Oram. Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. J. Biol. Chem. 262: 7439-7442, 1987.
13. Habenicht, A. J. R., P. Salbach, M. Georig, W. Zeh, U. Janssen-Timmen, C. Blattner, W. C. King, and J. A. Glomset. The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor. Nature Lond. 345: 634-636, 1990.
14. Havel, R. J., H. A. Eder, and J. H. Bragdon. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353, 1955.
15. Hockland, B., A. J. Mendez, and J. F. Oram. Cellular localisation and characterization of proteins that bind high density lipoprotein. J. Lipid Res. 33: 1335-1342, 1992.
16. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52: 2745-2753, 1973.
17. Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature Lond. 343: 531-535, 1990.
18. Locher, R.,A. Sachinidis, A. Steiner, and W. Vetter. Attenuation of the low density lipoprotein-activated signalling system by calcium blockers in human lymphocytes. Clin. Sci. Lond. 78: 509-514, 1990.
19. Lopes-Virella, M. F., and G. Virella. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41, Suppl. 2: 86-91, 1992.
20. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
21. Lyons, T. J. Lipoprotein glycation and its metabolic consequences Diabetes 41, Suppl. 2: 67-73, 1992.
22. Lyons, T. J. Glycation and oxidation: a role in the pathology of atherosclerosis. Am. J. Cardiol. 71: 26B-31B, 1993.
23. McGrath, L. T., and R. J. Elliott. Formation of a lipid gradient across the human aortic wall during ageing and the development of atherosclerosis. Atherosclerosis 87: 211-220, 1991.
24. Morel, D., P. E. DiCorletto, and G. M. Chisolm. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4: 357-364, 1984.
25. Morel, D. W., J. R. Hessler, and G. M. Chisolm. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24: 1070-1076, 1983.
26. Myers, D. E., N. H. Fidge, H. Stanton, and R. G. Larkins. The effects of low density lipoprotein and high density lipoprotein on phosphoinositide hydrolysis in bovine aortic endothelial cells. Atherosclerosis 92: 9-16, 1992.
27. Nel, A. E., M. C. De Beer, E. G. Shephard, A. F. Strachan, M. L. Vandenplas, and F. C. De Beer. Phosphorylation of human serum amyloid A protein by protein kinase C. Biochem. J. 255: 29-34, 1988.
28. Nolan, R. D., G. J. Dusting, and T. J. Martin. Phospholipase inhibition and the mechanism of angiotensin-induced prostacyclin release from rat messenteric vasculature. Biochem. Pharmacol. 30: 2121-2125, 1981.
29. Nordestgaard, B. G., E. Hjelms, S. Stender, and K. Kjeldsen. Different efflux pathways for high and low density lipoproteins from porcine aortic intima. Arteriosclerosis 10: 477-485, 1990.
30. Resink, T. J., V. A. Tkachuk, J. Bernhardt, and F. R. Buhler. Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arteriosclerosis Thromb. 12: 278-285, 1992.
31. Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature Lond. 343: 531-535, 1990.
32. Sachinidis, A., R. Locher, T. Mengden, A. Steiner, and W. Vetter. Vasoconstriction: a novel activity for low density lipoprotein. Biochem. Biophys. Res. Commun. 163: 315-320, 1989.
33. Sachinidis, A., R. Locher, T. Mengden, and W. Vetter. Low density lipoprotein elevates intracellular calcium and pH in vascular smooth muscle cells and fibroblasts without mediation of the low density lipoprotein receptor. Biochem. Biophys. Res. Commun. 167: 353-359, 1990.
34. Salbach, P. B., U. Janben-Timmen, and A. J. Habenicht. A new role for the low-density lipoprotein receptor pathway: to deliver arachidonic acid to cells for eicosanoid formation. Atherosclerosis Rev. 23: 221-227, 1991.
35. Scott-Burden, T., T. J. Resink, A. W. A. Hahn, U. Baur, R. J. Box, and F. R. Buhler. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoproteins. J. Biol. Chem. 264: 12582-12589, 1989.
36. Spector, A. A., A. M. Scanu, T. L. Kaduce, P. H. Figard, G. M. Fless, and R. L. Czervionke. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. J. Lipid Res. 26: 288-297, 1985.
37. 125I-labelled low density lipoprotein. Biochim. Biophys. Acta 620: 631-635, 1980.
38. Tauber, J.-P., J. Cheng, and D. Gospodarowicz. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J. Clin. Invest. 66: 696-708, 1980.
39. Tozuka, M., and N. Fidge. Purification and characterization of two high-density lipoprotein-binding proteins from rat and human liver. Biochem. J. 261: 239-244, 1989.
40. Weisser, B., R. Locher, T. Mengden, A. Sachinidis, and W. Vetter. Oxidized low-density lipoproteins in atherogenesis: possible mechanisms of action. J. Cardiovasc. Pharmacol. 19, Suppl. 2: 4-7, 1992.
41. Weisser, B., R. Locher, T. Mengden, and W. Vetter. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arteriosclerosis Thromb. 12: 231-236, 1992.